The intricate interactions between host microbiota and immune cells within barrier tissues—such as the gut, skin, and lungs—are central to preserving immune homeostasis, reinforcing epithelial integrity, and regulating inflammation. Key mediators, including microbial metabolites like short-chain fatty acids (SCFAs) and tryptophan derivatives, and signaling pathways involving Toll-like receptors (TLRs) and NOD-like receptors (NLRs), orchestrate immune responses that distinguish commensals from pathogens. Dysbiosis, characterized by microbial imbalance, disrupts these regulatory mechanisms and contributes to chronic conditions such as inflammatory bowel disease (IBD), atopic dermatitis, and asthma. Importantly, emerging microbiome-based therapies—including probiotics, prebiotics, postbiotics, and fecal microbiota transplantation (FMT)—offer promising strategies to restore microbial balance and improve immune function. Coupled with advances in multi-omics and artificial intelligence, these approaches support precision medicine models that tailor interventions to individual microbial and immune profiles. This review synthesizes recent evidence to highlight the therapeutic opportunities, challenges, and future directions in leveraging host–microbiome interactions for clinical immunology.
Chigozie, Victor U., Enyi, Emmanuel O., Akwari, Ada A. et al. Host-microbe interactions at barrier tissues and immunomodulation: a scoping review. // Discover Bacteria. – 2025. – DOI: 10.1007/s44351-025-00037-3. – URL: http://link.springer.com/openurl/fulltext?id=doi:10.1007/s44351-025-00037-3
Chigozie, Victor U, Enyi, Emmanuel O, Akwari, Ada A, Esimone, & Charles O (2025). Host-microbe interactions at barrier tissues and immunomodulation: a scoping review. Discover Bacteria. https://doi.org/10.1007/s44351-025-00037-3
Chigozie, et al. “Host-microbe interactions at barrier tissues and immunomodulation: a scoping review.” Discover Bacteria, 2025. doi:10.1007/s44351-025-00037-3.
@article{Chigozie2025,
title = {Host-microbe interactions at barrier tissues and immunomodulation: a scoping review},
author = {Chigozie and U., Victor and Enyi and O., Emmanuel and Akwari and A., Ada and Esimone and O., Charles},
journal = {Discover Bacteria},
year = {2025},
doi = {10.1007/s44351-025-00037-3},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s44351-025-00037-3}
}
Background Diesel exhaust particles (DEP) are a major component of combustion-derived PM_2.5 and contain complex mixtures of organic and inorganic contaminants associated with elemental carbon (black carbon). Diesel particulate matter...
Background Triptolide (TP), a bioactive diterpenoid derived from Tripterygium wilfordii Hook F., exhibits potent anti-inflammatory and immunosuppressive activities but has a narrow therapeutic window and documented toxicities in...
Background Residents living near smelters and abandoned metal mines may experience chronic heavy metal exposure through multiple environmental pathways. Proteomic profiling provides a promising approach for identifying early biological...
Backgrounds Micro- and nanoplastics are associated with metabolic toxicity, but their effects on hepatic cholesterol homeostasis and potential mitigating interventions remain insufficiently characterized. Objectives To characterize...
Background Per- and polyfluoroalkyl substances (PFAS) are persistent environmental contaminants that accumulate in human tissues and may cause prolonged cellular and organ damage. Ferroptosis, an iron-dependent form of regulated cell...